The paradigm of healthcare delivery is undergoing a fundamental and rapid transformation, moving away from traditional in-person visits toward a more accessible, data-driven, and remote model. This evolution is not merely a consequence of recent global events but the culmination of technological
We are joined today by Ivan Kairatov, a biopharma expert at the forefront of medical technology and innovation. We will be exploring a groundbreaking AI-powered tool that promises to transform the early detection of heart valve disease, a condition often called a "silent epidemic." Our conversation
The decision to undergo a total hip replacement, a procedure performed hundreds of thousands of times annually, often comes with an uncertain road to recovery, yet a new wave of artificial intelligence is beginning to chart that path with unprecedented clarity. Predictive AI for surgery represents
As a biopharma expert with a deep background in research and technology, Ivan Kairatov has a unique perspective on the intersection of artificial intelligence and frontline medicine. His work focuses on how innovations like causal modeling can translate complex data into life-saving actions. Today,
The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
Today we’re speaking with Ivan Kairatov, a biopharma expert with a deep understanding of how technology and innovation are reshaping the industry. We'll be exploring the fascinating and complex gap between the theoretical promise of AI in medicine and its real-world performance. The conversation
